STOCK TITAN

Duncan McKechnie proposes sale of VRTX shares (VRTX) in Form 144

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

Issuer reported proposed sales of Common Stock via Form 144 by Duncan J. McKechnie. The filing lists two proposed dispositions: $2,394,365.00 for 4,910 shares on 02/25/2026 and $1,158,306.10 for 2,437 shares on 03/04/2026.

The filing also records restricted stock vesting events dated 02/10/2026 and 02/17/2026, including a vesting of 612 compensation shares on 02/17/2026. The entries identify Fidelity Brokerage Services LLC and NASDAQ as custodial/market references.

Positive

  • None.

Negative

  • None.

Insights

Two small, disclosed dispositions by Duncan J. McKechnie are reported on Form 144.

The filing documents proposed sales of 4,910 shares ($2,394,365.00) on 02/25/2026 and 2,437 shares ($1,158,306.10) on 03/04/2026. These are specified as transactional entries under Form 144 and reflect individual dispositions rather than company actions.

Timing and routing details are limited to the dates shown; cash‑flow recipients and whether sales were completed are not specified in the excerpt. Subsequent filings would confirm execution and post‑transaction holdings.

Form 144 disclosure aligns with required notice for proposed brokered sales by an affiliate.

The record lists restricted stock vesting on 02/10/2026 and 02/17/2026, with 612 shares shown for 02/17/2026, indicating acquired compensation shares subject to potential sale reporting. The presence of Fidelity Brokerage Services LLC is noted for routing.

Regulatory status and any limitations (e.g., sale timing or volume caps) are not included in the excerpt; follow‑up filings may provide completion or Rule 144 compliance detail.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What sales does the VRTX Form 144 disclose?

The Form 144 discloses proposed sales of 4,910 shares ($2,394,365.00) and 2,437 shares ($1,158,306.10). The transactions are dated 02/25/2026 and 03/04/2026.

Who is the reporting person on the VRTX Form 144?

The filing shows Duncan J. McKechnie as the reporting person. The entries list his address and the proposed sale dates of 02/25/2026 and 03/04/2026.

Does the filing show any restricted stock vesting for VRTX?

Yes, the excerpt records restricted stock vesting events on 02/10/2026 and 02/17/2026, including 612 compensation shares vesting on 02/17/2026.

Does the Form 144 confirm the sales were completed?

No; the Form 144 lists proposed dispositions with dates and amounts but does not confirm execution or settlement. Completion status is not specified in the provided excerpt.

Which broker or market is referenced in the VRTX filing?

The excerpt references Fidelity Brokerage Services LLC at 900 Salem Street, Smithfield, RI, and identifies NASDAQ as the market routing reference in the securities section.
Vertex Pharmaceuticals Inc

NASDAQ:VRTX

View VRTX Stock Overview

VRTX Rankings

VRTX Latest News

VRTX Latest SEC Filings

VRTX Stock Data

126.81B
252.98M
Biotechnology
Pharmaceutical Preparations
Link
United States
BOSTON